ZA904310B - Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor - Google Patents
Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitorInfo
- Publication number
- ZA904310B ZA904310B ZA904310A ZA904310A ZA904310B ZA 904310 B ZA904310 B ZA 904310B ZA 904310 A ZA904310 A ZA 904310A ZA 904310 A ZA904310 A ZA 904310A ZA 904310 B ZA904310 B ZA 904310B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibitor
- coa reductase
- hmg coa
- atherosclerotic disease
- squalene synthetase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36152089A | 1989-06-05 | 1989-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA904310B true ZA904310B (en) | 1991-03-27 |
Family
ID=23422378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA904310A ZA904310B (en) | 1989-06-05 | 1990-06-05 | Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor |
Country Status (7)
Country | Link |
---|---|
US (1) | USH1286H (ja) |
EP (1) | EP0401705A3 (ja) |
JP (1) | JPH0320226A (ja) |
AU (1) | AU5495090A (ja) |
CA (1) | CA2016467A1 (ja) |
HU (1) | HUT54059A (ja) |
ZA (1) | ZA904310B (ja) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2018470A1 (en) * | 1989-07-17 | 1991-01-17 | Scott Adams Biller | Phosphorus-containing squalene synthetase inhibitors and method |
HU9203780D0 (en) * | 1991-12-12 | 1993-03-29 | Sandoz Ag | Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them |
WO1993013801A1 (en) * | 1992-01-17 | 1993-07-22 | The Procter & Gamble Company | Treatment for atherosclerosis |
US5631365A (en) | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
DK0930076T3 (da) * | 1996-07-15 | 2005-01-31 | Sankyo Co | Farmaceutiske præparater omfattende CS-866 og insulinresistensforbedrende midler og deres anvendelse i behandlingen af arteriosclerose og xanthom |
US6203785B1 (en) | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
US6469035B1 (en) * | 1997-07-31 | 2002-10-22 | Eugenio A. Cefali | Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid |
BR9815548A (pt) * | 1997-07-31 | 2000-11-07 | Kos Pharma Inc | Composição farmacêutica para administração em dose única diária para alteração de lipìdios num indivìduo sem causar hepatotoxicidade induzida por drogas, miopatia ou rabdomiólise, comprimido revestido para administração oral e método para administração de dita composição |
US6180660B1 (en) | 1997-08-26 | 2001-01-30 | Merck & Co., Inc. | Cholesterol-lowering therapy |
SI1009400T1 (en) | 1997-08-29 | 2005-04-30 | Pfizer Inc. | Combination therapy comprising atorvastatin and an antihypertensive agent |
IE970731A1 (en) * | 1997-10-07 | 2000-10-04 | Fuisz Internat Ltd | Product and method for the treatment of hyperlipidemia |
US6083497A (en) | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
JP2003524582A (ja) * | 1997-12-12 | 2003-08-19 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 抗高脂血症性スタチン−Lp(a)阻害剤配合物 |
US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
SE9903028D0 (sv) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
WO2001015674A2 (en) * | 1999-08-30 | 2001-03-08 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
CZ305202B6 (cs) | 2001-01-26 | 2015-06-10 | Merck Sharp & Dohme Corp. | Farmaceutický prostředek |
DE60216890T2 (de) | 2001-01-26 | 2007-08-30 | Schering Corp. | Kombinationen von einem hemmer der sterol-absorption und einem ppar-aktivator zur behandlung von kardiovaskulären indikationen |
US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
US20060127474A1 (en) | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
WO2002098353A2 (en) * | 2001-06-05 | 2002-12-12 | Merck & Co., Inc. | Compositions and methods for inhibiting bone resorption |
US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
US6576256B2 (en) | 2001-08-28 | 2003-06-10 | The Brigham And Women's Hospital, Inc. | Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
AU2002336609B2 (en) | 2001-09-21 | 2006-08-24 | Merck Sharp & Dohme Corp. | Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
US7107198B2 (en) * | 2001-11-02 | 2006-09-12 | Sun Microsystems, Inc. | Automatic generation of reduced-size circuit models including inductive interaction |
EP1485391B1 (en) | 2002-03-19 | 2006-08-23 | Genzyme Corporation | Phosphate transport inhibitors |
MXPA05004811A (es) | 2002-11-06 | 2005-07-22 | Schering Corp | Inhibidores de absorcion de colesterol para el tratamiento de trastornos autoinmunes. |
JP4589919B2 (ja) * | 2003-03-07 | 2010-12-01 | シェーリング コーポレイション | 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用 |
US7459442B2 (en) * | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
CN1756755A (zh) | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
US7235543B2 (en) * | 2003-03-07 | 2007-06-26 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
JP2008533044A (ja) * | 2005-03-11 | 2008-08-21 | ホン コン ナイトリック オキサイド リミテッド | 内皮機能不全、アンギナおよび糖尿病のための組合せ治療 |
US20100190697A1 (en) * | 2006-09-13 | 2010-07-29 | The Trustees Of Columbia University In The City If | Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass |
WO2012170417A2 (en) | 2011-06-06 | 2012-12-13 | Warsaw Orthopedic, Inc. | Methods and compositions to enhance bone growth comprising a statin |
WO2019076269A1 (zh) | 2017-10-16 | 2019-04-25 | 清华大学 | 甲羟戊酸通路抑制剂及其药物组合物 |
DE102018110626B4 (de) | 2018-05-03 | 2020-01-30 | Infineon Technologies Ag | Verarbeitung von Radarsignalen |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4046889A (en) | 1976-02-13 | 1977-09-06 | E. R. Squibb & Sons, Inc. | Azetidine-2-carboxylic acid derivatives |
US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
US4450171A (en) | 1980-08-05 | 1984-05-22 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US4404144A (en) | 1981-02-20 | 1983-09-13 | G. D. Searle & Co. | Unsaturated analogs of β-alkyl-β-hydroxy glutaric acid and esters thereof |
US4448784A (en) | 1982-04-12 | 1984-05-15 | Hoechst-Roussel Pharmaceuticals, Inc. | 1-(Aminoalkylphenyl and aminoalkylbenzyl)-indoles and indolines and analgesic method of use thereof |
US4452790A (en) | 1982-06-23 | 1984-06-05 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives |
JPS591415A (ja) | 1982-06-28 | 1984-01-06 | Mochida Pharmaceut Co Ltd | 循環系疾患治療剤 |
US4499289A (en) | 1982-12-03 | 1985-02-12 | G. D. Searle & Co. | Octahydronapthalenes |
DE3536687A1 (de) | 1985-10-15 | 1987-04-16 | Hoechst Ag | Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit |
US4654363A (en) * | 1985-11-04 | 1987-03-31 | Merck & Co., Inc. | Synthetic analogs of mevinolin |
US4759923A (en) * | 1987-06-25 | 1988-07-26 | Hercules Incorporated | Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives |
US4871721A (en) * | 1988-01-11 | 1989-10-03 | E. R. Squibb & Sons, Inc. | Phosphorus-containing squalene synthetase inhibitors |
EP0356866A3 (en) * | 1988-08-29 | 1991-03-27 | E.R. SQUIBB & SONS, INC. | Phosphorus-containing squalene synthetase inhibitors and method |
-
1990
- 1990-05-10 CA CA002016467A patent/CA2016467A1/en not_active Abandoned
- 1990-05-11 AU AU54950/90A patent/AU5495090A/en not_active Abandoned
- 1990-06-01 EP EP19900110475 patent/EP0401705A3/en not_active Withdrawn
- 1990-06-04 HU HU903320A patent/HUT54059A/hu unknown
- 1990-06-05 ZA ZA904310A patent/ZA904310B/xx unknown
- 1990-06-05 JP JP2147164A patent/JPH0320226A/ja active Pending
- 1990-10-18 US US07/599,570 patent/USH1286H/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0401705A3 (en) | 1993-01-07 |
HUT54059A (en) | 1991-01-28 |
CA2016467A1 (en) | 1990-12-05 |
AU5495090A (en) | 1990-12-06 |
EP0401705A2 (en) | 1990-12-12 |
HU903320D0 (en) | 1990-10-28 |
JPH0320226A (ja) | 1991-01-29 |
USH1286H (en) | 1994-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA904310B (en) | Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor | |
AU7096498A (en) | Apparatus and method for recognising and determining the position of a part of an animal | |
AU5506298A (en) | Apparatus and method for recognising and determining the position of a part of an animal | |
AU7898094A (en) | Method and device for processing a signal | |
EP0432497A3 (en) | Resin-coated steel sheet for drawn-and-ironed cans and drawn-and-ironed cans manufactured therefrom | |
GB9405242D0 (en) | Developers for ps plates and replinishers therefor | |
EP0663616A3 (en) | Radiation sensitive material and method of making a pattern. | |
EP0645630A3 (en) | Method for determining the presence of a pivka and reagent therefor. | |
AU676345B2 (en) | Stainless steel for coins and method for manufacturing stainless steel coins | |
FR2642311B1 (fr) | Association d'un inhibiteur de la hmg coa reductase et d'un inhibiteur de la squalene synthetase, permettant d'abaisser la cholesterolemie | |
GB2283096B (en) | Method and device for ultrasonic distance measurement | |
GB9422409D0 (en) | Extensometer and support for an extensometer | |
IL107005A (en) | Method for the detection and differentiation of neoplastic tissue | |
EP0405795A3 (en) | Method and apparatus for a target determining apparatus having increased range | |
GR3025772T3 (en) | Method and device for determining the location of a target. | |
EP0323866A3 (en) | Novel hmg-coa reductase inhibitors | |
EP0461548A3 (en) | Method for preventing a second heart attack employing and hmg coa reductase inhibitor | |
AU6359596A (en) | Flame-straightening process and device for metal parts | |
AU6600594A (en) | Method and apparatus for including the states of nonscannable parts in a scan chain | |
GB2284120B (en) | Method and device for determination of direction | |
EP0415488A3 (en) | 7-substituted hmg-coa reductase inhibitors | |
AU6221694A (en) | Method and device for processing manure | |
GB2285061B (en) | A method of processing ferrous materials | |
AU5102493A (en) | A method for the detection and treatment of prostate disease | |
HU9301440D0 (en) | Method and device for harmlessing and utilizing waste products |